An excess concentration of oxysterols in the plasma is cytotoxic to cultured endothelial cells

Atherosclerosis

Volumn 149, Issue 1, 2000, Pages 191-197

  Zhou, Qi ^a   Wasowicz, Erwin ^c   Handler, Bruce ^d   Fleischer, Leslie ^d   Kummerow, Fred A ^a,b  

^a Harlan E Moore Heart Research Foundation   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c Posnan University   (Poland)

^d Carle Hospital   (United States)

Author keywords

Atherosclerosis; Ca2+ influx; Cholesterol synthesis; Cultured human endothelial cells; Cytotoxicity; Oxysterols; Stenosis; Thymidine incorporation

Indexed keywords

7 OXOCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; CALCIUM ION; EPOXIDE; MEVALONOLACTONE; OXYSTEROL; THYMIDINE;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CULTURE MEDIUM; CYTOTOXICITY; ENDOTHELIUM CELL; FEMALE; HEART CATHETERIZATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL TRANSPORT, ACTIVE; CALCIUM CHANNELS; CELLS, CULTURED; CHOLESTEROL; CORONARY DISEASE; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HEART CATHETERIZATION; HUMANS; HYDROXYCHOLESTEROLS; KETOCHOLESTEROLS; MALE; MIDDLE AGED; PROBABILITY; STEROLS;

EID: 0033993486     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00343-3     Document Type: Article

References (60)

1. Navab M., Berliner J.A., Watson A.D., Hama S.Y., Territo M.C., Lusis A.J. The yin and yang of oxidation in the development of the fatty streak. Arterioscler. Thromb. Vasc. Biol. 16:1996;831-842.
2. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis. 141:1998;1-15.
3. Kovacs I.B., Jahangiri M., Rees G.M., Gorog P. Elevated plasma lipid hydroperoxides in patients with coronary artery disease. Am. Heart J. 134:1997;572-576.
4. Mosca L., Rubenfire M., Tarshis T., Tsai A., Pearson T. Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease. Am. J. Cardiol. 80:1997;825-830.
5. Holvoet P., Stassen J.-M., Cleemput J.V., Collen D., Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18:1998;100-107.
6. Maggi E., Finardi G., Poli M., Bollati P., Filipponi M., Stefano P.L., Paolini G., Grossi A., Clot P., Albano E. et al. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk. Coron. Artery Dis. 4:1993;1119-1122.
7. Sparrow C.P., Doebber T.W., Olszewski J., Wu M.S., Ventre J., Stevens K.A., Chao Y.S. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine. J. Clin. Invest. 89:1992;1885-1891.
8. Ide N., Lau B.H. Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury. J. Pharm. Pharmacol. 49:1997;908-911.
9. Murugesan G., Chisolm G.M., Fox P.L. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J. Cell Biol. 120:1993;1011-1019.
10. Negre-Salvayre A., Fitoussi G., Reaud V., Pieraggi M.T., Thiers J.C., Salvayre R. A delayed and sustained rise of cytosolic calcium is elicited by oxidized LDL in cultured bovine aortic endothelial cells. FEBS Lett. 299:1992;60-65.
11. Nilsson J. Lipoproteins and inflammation in atherosclerosis. Fibrinolysis Proteolysis. 11(Suppl. 1):1997;129-132.
12. Hodis H.N., Kramsch D.M., Avogaro P., Bittolo-Bon G., Cazzolato G., Hwang J., Peterson H., Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J. Lipid Res. 35:1994;669-677.
13. Peng S., Morin R.J. Biological Effects of Cholesterol Oxides. 1992;7-31 CRC Press, Boca Raton, FL.
14. Mahfouz M.M., Kummerow F.A. Oxysterols and TBARS are among the LDL oxidation products which enhance thromboxane A2 synthesis by platelets. Prostaglandins Other Lipid Mediat. 56:1998;197-217.
15. Peng S.-K., Taylor C.B. Cholesterol autoxidation, health and arteriosclerosis. World Rev. Nutr. Diet. 44:1984;117-154.
16. Smith L.L., Johnson B.H. Biological activities of oxysterols. Free Radic. Biol. Med. 7:1989;285-332.
17. Peng S.-K., Taylor C.B., Hill J.C., Morin R.J. Cholesterol oxidation derivatives and arterial damage. Atherosclerosis. 54:1985;121-133.
18. Imai H., Werthessen N.T., Taylor B., Lee K.T. Angiotoxicity and arteriosclerosis due to contaminants of USP-grade cholesterol. Arch. Pathol. Lab. Med. 100:1976;565-572.
19. Bernheimer A.W., Robinson W.G., Linder R., Mullins D., Yip Y.K., Cooper N.S., Seidman I., Uwajima T. Toxicity of enzymically-oxidized low-density lipoprotein. Biochem. Biophys. Res. Commun. 148:1987;260-266.
20. Taylor C.B., Peng S.K. Cytotoxicity and atherogenicity of oxidized cholesterol. J. Am. Oil Chem. Soc. 62:1985;633.
21. Peng S.K., Tham P., Taylor C.B., Mikkelson B. Cytotoxicity of oxidation derivatives on cultured aortic smooth muscle cells and their effect on cholesterol biosynthesis. Am. J. Clin. Nutr. 32:1979;1033-1042.
22. Peng S.K., Taylor C.B., Mosbach E.H., Huang W.Y., Hill J., Mikkelson B. Distribution of 25-hydroxycholesterol in plasma lipoproteins and its role in atherogenesis. Atherosclerosis. 41:1982;395-402.
23. Brooks C.J.W., Harland W.A., Steel G. 26-Hydroxycholesterol and 7-ketocholesterol in human atheromatous plaques. Biochim. Biophys. Acta. 125:1966;620-622.
24. Fatmagalli R., Galli G., Urna G. Cholestanol and 26-hydroxycholesterol in normal and atherosclerotic human aorta. Life Sci. 10:1971;25-33.
25. Taylor F.R., Saucier S.E., Shown E.P., Parish E.J., Kandutsch A.A. Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase. J. Biol. Chem. 259:1984;12382-12387.
26. Kandutsch A.A., Chen H.W. Inhibition of sterol synthesis in cultured mouse cells by cholesterol derivatives oxygenated in the side chain. J. Biol. Chem. 249:1974;6057-6061.
27. Brown M.S., Dawna S.E., Goldstein J.L. Cholesterol ester formation in cultured human fibroblasts stimulated by oxygenated sterols. J. Biol. Chem. 250:1975;4025-4027.
28. Lorenzo J.L., Alloris M., Bernini F., Orsini A., Fumagalli L. Regulation of low density lipoprotein metabolism by 26-hydroxycholesterol in human fibroblasts. FEBS Lett. 218:1987;77-80.
29. Fornas E., Fortea A., Renau J., Camanas A. Cholesterol oxygenated derivatives induce erythrocyte accumulation and endothelium alterations in the aorta of rats. Turnover of endothelial cells in the apparently intact areas remains unchanged. Exp. Pathol. 31:1987;105-112.
30. Taylor C.B., Peng S.-K., Werthessen N.T., Tham P., Lee K.T. Spontaneously occurring angiotoxic derivatives of cholesterol. Am. J. Clin. Nutr. 32:1979;40-57.
31. Jimi S., Smith T.L., Kummerow F.A. 26-Hydroxycholesterol-stimulated DNA synthesis in smooth muscle cells and induction of endothelial injury using a coculture technique. Biochem. Med. Metab. Biol. 44:1990;114-125.
32. Kawamura K., Kummerow F.A. Effect of 25-hydroxycholesterol on cytotoxicity and prostacyclin production in cultured human umbilical arterial endothelial cells. Eicosanoids. 5:1992;29-34.
33. Zhou Q., Wasowicz E., Kummerow F.A. Failure of vitamin E to protect cultured human arterial smooth muscle cells against oxysterol-induced cytotoxicity. J. Am. Coll. Nutr. 14:1995;169-175.
34. Zhou Q., Smith T.L., Kummerow F.A. Cytotoxicity of oxysterols on cultured smooth muscle cells from human umbilical arteries. Proc. Soc. Exp. Biol. Med. 202:1993;75-80.
35. Cox D.C., Comai K., Goldstein A.L. Effect of cholesterol and 25-hydroxycholesterol on smooth muscle cell and endothelial cell growth. Lipids. 23:1988;85-88.
36. Baranowski A., Adams C.W.M., Bayliss High D.B., Bowyer D.B. Connective tissue responses to oxysterols. Atherosclerosis. 41:1982;255-266.
37. Higley N.A., Taylor S.L. The steatotic and cytotoxic effects of cholesterol oxides in cultured L cells. Food Chem. Toxicol. 22:1984;983-992.
38. Boissonneault G.A., Heiniger H.-J. 25-Hydrocholesterol induced elevations in 45Ca uptake: permeability changes in P815 cells. J. Cell. Physiol. 125:1985;471-475.
39. Pettersen K.S., Boberg K.M., Stabursvik A., Prydz H. Toxicity of oxygenated cholesterol derivatives toward cultured human umbilical vein endothelial cells. Arterioscler. Thromb. 11:1991;423-428.
40. Hu B., Jin D., Fan W., Peng S.K., Morin R.J. Effect of cholestanetriol on cytotoxicity and prostacyclin production in cultured rabbit aortic endothelial cells. Artery. 18:1991;87-98.
41. Boissonneault G.A., Hennig B., Ouyang C. Oxysterols, cholesterol biosynthesis, and vascular endothelial cell monolayer barrier function. Proc. Soc. Exp. Biol. Med. 196:1991;338-343.
42. 2+ uptake and lipid content in cultured human arterial smooth muscle cells treated with 26-hydroxycholesterol. Artery 1994;21:182-192.
43. Hennig B., Boissonneault G.A. Cholestan-3β,5α,6β-triol decreases barrier function of cultured endothelial cell monolayers. Atherosclerosis. 68:1987;255-261.
44. 45Ca uptake: correlation with depressed DNA synthesis. J. Cell. Physiol. 120:1984;151-156.
45. Moog C., Hergueux J., Italiano L., Luu B., Bischoff P. Inhibition of lymphocyte activation by 7,25-dihydroxy-cholesterol: a preliminary report. IRCS Med. Sci. 14:1986;1207-1208.
46. Kou I.L., Pikul J., Kummerow F.A. Influence of 26-hydroxycholesterol on the composition and function of gel-filtered platelets. J. Am. Coll. Nutr. 10:1991;114-122.
47. Szostek R., Kucuk O., Lis L.J., Tracy D., Mata R., Dey T., Kauffman J.W., Yachnin S., Westerman M.P. Effect of inserted oxysterols on phospholipid packing in noraml and sickle red blood cell membranes. Biochem. Biophy. Res. Commun. 180:1991;730-734.
48. Warren J.S., Ward P.A. Oxidative injury to the vascular endothelium. Am. J. Med. Sci. 292:1986;97-103.
49. Zhou Q., Kummerow F.A. The influence of 25-hydroxycholesterol on phosphatidylinositol content in cultured smooth muscle cells. Proc. Soc. Exp. Biol. Med. 206:1994;119-123.
50. 2+ content in cultured smooth muscle cells. Biomed. Environ. Sci. 10:1997;369-376.
51. Zhou Q., Jimi S., Smith T.L., Kummerow F.A. The effect of 25-hydroxycholesterol on accumulation of intracellular calcium. Cell Calcium. 12:1991;467-476.
52. Mahfouz M.M., Zhou Q., Kummerow F.A. Cholesterol oxides in plasma and lipoproteins of magnesium-deficient rabbits and effects of their lipoproteins on endothelial barrier function. Magnesium Res. 7:1994;207-222.
53. Smith T.L., Kummerow F.A. Effect of dietary vitamin E on plasma lipids and atherogenesis in restricted ovulator chickens. Atherosclerosis. 75:1989;105-109.
54. Drevon C.A., Weinstein D.B., Steinberg D. Regulation of cholesterol esterification and biosynthesis in monolayer cultures of normal adult rat hepatocytes. J. Biol. Chem. 255:1980;9128-9137.
55. Guardiola F., Codony R., Addis P.B., Rafecas M., Boatella J. Biological effects of oxysterols: current status. Food Chem. Toxicol. 34:1996;193-211.
56. Siperstein M.D. Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth. J. Lipid Res. 25:1984;1462-1468.
57. Tabacik C., Aliau S., Sainte-Marie J. Regulation of cholesterol biosynthesis at a stage after the 3-hydroxy-3-methylglutaryl-CoA reductase step, in normal and leukemic (L2C) guinea pig lymphocytes. Biochim. Biophys. Acta. 921:1987;405-410.
58. Ortiz de Montellano P.R., Beck J.P., Ourisson G. Regulation of sterol biosynthesis and lysis of cultured hepatoma cells: inhibition of lanosterol demethylation by hydroxysterols. Biochem. Biophys. Res. Commun. 90:1979;897-903.
59. Gaylor J.L., Delwiche C.V. Purification of a soluble rat liver protein that stimulates microsomal 4-methyl sterol oxidase activity. J. Biol. Chem. 251:1976;6638-6645.
60. Mahfouz M.M., Kawano H., Kummerow F.A. Effect of cholesterol-rich diets with and without added vitamins E and C on the severity of atherosclerosis in rabbits. Am. J. Clin. Nutr. 66:1997;1240-1249.